, Volume 47, Issue 3, pp 249–260 | Cite as

Drug-induced rotation in rats without lesions: Behavioral and neurochemical indices of a normal asymmetry in nigro-striatal function

  • Thomas P. Jerussi
  • Stanley D. Glick
Animal Studies


Normal unoperated rats were tested for rotation (i.e., circling behavior) in a spherical “rotometer” and dose-response relationships were generated using d-amphetamine, apomorphine, L-Dopa, haloperidol, and scopolamine. The rotation induced by amphetamine was significantly antagonized by alphamethyl-p-tyrosine and haloperidol, but not by diethyl-dithiocarbamate. The rotation elicited by apomorphine was unaffected by alpha-methyl-p-tyrosine. Rotation was not necessarily in the same direction with high and low doses of amphetamine, or amphetamine and apomorphine administered a week apart from each other. Dopaminergic-cholinergic interactions were evident, since pilocarpine antagonized amphetamine-induced rotation whereas scopolamine did not; scopolamine elicited rotation in the same direction as that induced by amphetamine. Left and right striatal dopamine and tel-diencephalic norepinephrine levels were determined in rats injected with various doses of amphetamine and tested for rotation. There were significant bilateral differences in striatal dopamine which were related to the direction of rotation. Since amphetamine was found to be equally distributed to the two sides of the brain, the difference in striatal dopamine appeared to be the neurochemical substrate for rotation in normal rats. These results suggest that normal rats have asymmetrical levels of striatal dopamine as well as an asymmetrical complement of striatal dopamine receptors.

Key words

Rotation d-Amphetamine Apomorphine Scopolamine L-Dopa Haloperidol 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Andén, N. E.: Effects of amphetamine and some other drugs in central catecholamine mechanisms. In: Amphetamines and related compounds, E. Costa and S. Garattini, eds., pp. 447–462. New York: Raven Press 1970Google Scholar
  2. Andén, N. E., Bedard, P.: Influences of cholinergic mechanisms on the function and turnover of brain dopamine. J. Pharm. Pharmacol. 23, 460–462 (1971)Google Scholar
  3. Andén, N. E., Butcher, S. G., Corrodi, H., Fuxe, K., Ungerstedt, U.: Receptor activity and turnover of dopamine and norepinephrine after neuroleptics. Europ. J. Pharmacol. 11, 303–314 (1970)Google Scholar
  4. Andén, N. E., Dahlstrom, A., Fuxe, K., Larsson, K.: Functional role of the nigro-neostriatal dopamine neurons. Acta pharmacol. et Toxicol 24, 263–274 (1966)Google Scholar
  5. Anggard, E., Gunne, L. M., Niklasson, F.: Gas chromatographic determination of amphetamine in blood, tissue, and urine. J. Scand. Clin. Lab. Invest. 26, 137–143 (1970)Google Scholar
  6. Arbuthnott, G. W., Crow, T. J.: Relation of contraversive turning to unilateral release of dopamine from the nigro-striatal pathway in rats. Exp. Neurol. 30, 484–491 (1971)Google Scholar
  7. Axelrod, J.: Amphetamine: metabolism, physiological disposition and its effects on catecholamine storage. In: Amphetamines and related compounds, E. Costa and S. Garattini, eds., pp. 207–215. New York: Raven Press 1970Google Scholar
  8. Bak, I. J., Hassler, R., Kim, J. S., Kataoka, K.: Amantadine actions on acetylcholine and GABA in striatum and substantia nigra of rat in relation to behavioral changes. J. neural Trans. 33, 45–61 (1972)Google Scholar
  9. Bartholini, G., Pletscher, A.: Drugs affecting monoamines in the basal ganglia. Advanc. Biochem. Psychopharmacol. 6, 135–148 (1972)Google Scholar
  10. Brodie, B. B., Cho, A. K., Gessa, G. L.: Possible role of p-hydroxynorephedrine in the depletion of norepinephrine, induced by d-amphetamine and in tolerance to this drug. In: Amphetamine and related compounds, E. Costa and S. Garattini, eds., pp. 217–229. New York: Raven Press 1970Google Scholar
  11. Buchwald, N. A., Wyers, E. J., Lauprecht, C. W., Heuser, G.: The “caudate-spindle”. IV. A behavioral index of caudate-induced inhibition. Electroenceph. clin. Neurophysiol. 13, 531–537 (1961)Google Scholar
  12. Bunney, B. S., Aghajanian, G. K., Roth, R. H.: Comparison of the effects of L-Dopa, amphetamine and apomorphine on the firing rate of rat dopaminergic neurons. Nature New Biol. 245, 123–125 (1973)Google Scholar
  13. Carlsson, A., Lindqvist, M., Fuxe, K., Hokfelt, T.: Histochemical and biochemical effects of diethyldithiocarbamate on tissue catecholamines. J. Pharm. Pharmacol. 18, 60–62 (1966)Google Scholar
  14. Christie, J. E., Crow, T. J.: Turning behavior as an index of the action of amphetamine and ephedrines on central dopamine-containing neurons. Brit. J. Pharmacol. 43, 658–667 (1971)Google Scholar
  15. Collins, G. G. S.: Inhibition of dopamine-beta-hydroxylase by diethyldithiocarbamate. J. Pharm. Pharmacol. 17, 526–527 (1965)Google Scholar
  16. Corrodi, H., Fuxe, K., Hamberger, B., Ljungdahl, A.: Studies on central and peripheral noradrenaline neurons using a new dopamine-beta-hydroxylase inhibitor. Europ. J. Pharmacol. 12, 145–155 (1970)Google Scholar
  17. Costall, B., Naylor, R. J.: On the mode of action of apomorphine. Europ. J. Pharmacol. 21, 350–361 (1973)Google Scholar
  18. Costall, B., Naylor, R. J., Olley, J. E.: Catalepsy and circling behavior after intracerebral injections of neuroleptic, cholinergic and anticholinergic agents into the caudate-putamen, globus pallidus and substantia nigra of rat brain. Neuropharmacology 11, 645–663 (1972)Google Scholar
  19. Costall, B., Olley, J. E.: Cholinergic and neuroleptic induced catalepsy: modification by lesions in the globus pallidus and substantia nigra. Neuropharmacology 10, 581–591 (1971)Google Scholar
  20. Crow, T. J.: The relationship between lesion site dopamine neurons, and turning behavior in the rat. Exp. Neurol 32, 247–255 (1971)Google Scholar
  21. Dominic, J. A., Moore, K. E.: Supersensitivity to the central stimulant actions of adrenergic drugs following discontinuation of a chronic diet of a-methyl-tyrosine. Psychopharmacologia (Berl.) 15, 96–101 (1969)Google Scholar
  22. Ernst, A. M.: Relation between the action of dopamine and apomorphine and their O-methylated derivates upon the CNS. Psychopharmacologia (Berl.) 7, 391–399 (1965)Google Scholar
  23. Ernst, A. M.: Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats. Psychopharmacologia (Berl.) 10, 316–323 (1967)Google Scholar
  24. Gianutsos, G., Drawbaugh, R. B., Hynes, M. D., Lal, H.: Behavioral evidence for dopaminergic supersensitivity after chronic haloperidol. Life Sci. 14, 887–889 (1974)Google Scholar
  25. Glick, S. D., Greenstein, S.: Possible modulating influence of frontal cortex on nigro-striatal function. Brit. J. Pharmacol. 49, 316–321 (1973)Google Scholar
  26. Glick, S. D., Jerussi, T. P., Waters, D. H., Green, J. P.: Amphet-amine-induced changes in striatal dopamine and acetylcholine levels in relationship to rotation (circling behavior) in rats. Biochem. Pharmacol. 23, 3223–3225 (1974)Google Scholar
  27. Goldstein, M.: Inhibition of norepinephrine at the dopamine-beta-hydroxylation stage. Pharmacol. Rev. 18, 77–82 (1966)Google Scholar
  28. Goldstein, M., Freeman, L. S., Backstrom, T.: The inhibition of catecholamine biosynthesis by apomorphine. J. Pharm. Pharmacol. 22, 715–717 (1970)Google Scholar
  29. Greenstein, S., Glick, S. D.: Improved automated apparatus for recording rotation (circling behavior) in rats or mice. Pharmacol. Biochem. Behav. 3, 507–510 (1975)Google Scholar
  30. Harris, J. E., Baldessarini, R. J., Roth, R. H.: Amphetamine-induced inhibition of tyrosine hydroxylation in homogenates of rat corpus striatum. Neuropharmacology 14, 457–471 (1975)Google Scholar
  31. Jerussi, T. P., Glick, S. D.: Amphetamine-induced rotation in rats without lesions. Neuropharmacology 13, 283–286 (1974)Google Scholar
  32. Jerussi, T. P., Glick, S. D.: Apomorphine-induced rotation in normal rats and interaction with unilateral caudate lesions. Psychopharmacologia (Berl.) 40, 329–334 (1975)Google Scholar
  33. Keller, H. H., Bartholini, G., Pletscher, A.: Drug-induced changes of striatal cholinergic and dopaminergic functions in rats with spreading depression. J. Pharm. Pharmacol. 25, 433–436 (1973)Google Scholar
  34. Kirby, R. J.: Caudate nucleus and arousal in the rat. J. comp. physiol. Psychol. 85, 82–96 (1973)Google Scholar
  35. Kuczenski, R.: Effects of catecholamine releasing agents on synaptosomal dopamine biosynthesis: multiple pools of dopamine or multiple forms of tyrosine hydroxylase. Neuropharmacology 14, 1–10 (1975)Google Scholar
  36. Laverty, R., Taylor, K. M.: The fluorometric assay of catecholamines and related compounds. Analyt. Biochem. 22, 269–279 (1968)Google Scholar
  37. Leonard, B. E., Shallice, S. A.: Some neurochemical effects of amphetamine, methylamphetamine and p-bromomethylamphetamine in the rat. Brit. J. Pharmacol. 41, 198–212 (1971)Google Scholar
  38. Lippman, W., Lloyd, K.: Dopamine-beta-hydroxylase inhibition by dimethyldithiocarbamate and related compounds. Biochem. Pharmacol. 18, 2507–2516 (1969)Google Scholar
  39. Marsden, C. A., Guldberg, H. C.: The role of monoamines in rotation induced or potentiated by amphetamine after nigral, raphe and mesencephalic reticular lesions in the rat brain. Neuropharmacology 12, 195–224 (1973)Google Scholar
  40. McKenzie, G. M., Gordon, R. J., Vilk, K.: Some biochemical and behavioral correlates of a possible animal model of human hyperkinetic syndromes. Brain Res 47, 439–456 (1972)Google Scholar
  41. Mennear, J. H.: Interactions between central cholinergic agents and amphetamine in mice. Psychopharmacologia (Berl.) 7, 107–114 (1965)Google Scholar
  42. Muller, P., Seeman, P.: Neuroleptics: A relation between cataleptic and anti-turning actions, and role of the cholinergic system. J. Pharm. Pharmacol. 26, 981–984 (1974)Google Scholar
  43. Naylor, R. J., Olley, J. E.: Modification of the behavioral changes by amphetamine in the rat by lesions of the caudate nucleus, the caudate-putamen and globus pallidus. Neuropharmacology 11, 91–99 (1972)Google Scholar
  44. Noonan, J. S., Murdick, P. W., Ray, R. S.: A method for detecting amphetamine using gas chromatography of a halogenated derivative. J. Pharmacol. exp. Ther. 168, 205–209 (1968)Google Scholar
  45. Overstreet, D. H., Vasquez, B. J., Russell, R. W.: Reduced behavioural effects of intrahippocampally administered carbachol in rats with low cholinesterase activity. Neuropharmacology 13, 911–917 (1974)Google Scholar
  46. Potegal, M.: Role of the caudate nucleus in spatial orientation of rats. J. comp. physiol. Psychol. 69, 756–764 (1969)Google Scholar
  47. Sethy, V. H., Van Woert, M. H.: Modification of striatal acetylcholine concentration by dopamine receptor agonists and antagonists. Res. Comm. chem. Path. Pharmacol. 8, 13–28 (1974)Google Scholar
  48. Smith, C. B.: Effects of d-amphetamine upon brain amine content and locomotor activity of mice. J. Pharmacol. exp. Ther. 147, 96–102 (1965)Google Scholar
  49. Snyder, S. H., Taylor, K. M.: Assay of biogenic amines and their deaminating enzymes in animal tissue. In: Research methods in neurochemistry, N. Marks and R. Rodnight, eds., pp. 287–315. New York: Plenum Press 1972Google Scholar
  50. Spector, S., Sjoerdsma, A., Udenfriend, S.: Blockade of endogenous norepinephrine synthesis by alpha-methyl-tyrosine an inhibitor of tyrosine hydroxylase. J. Pharmacol. exp. Ther. 147, 86–95 (1965)Google Scholar
  51. Tarsy, D., Baldessarini, R. J.: Behavioral supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic functions of catecholamines. Neuropharmacology 13, 927–940 (1974)Google Scholar
  52. Ungerstedt, U.: Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behavior. Acta physiol. scand., Suppl. 367, 49–68 (1971a)Google Scholar
  53. Ungerstedt, U.: Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta physiol. scand., Suppl. 367, 69–93 (1971b)Google Scholar
  54. Ungerstedt, U., Arbuthnott, G. W.: Quantitative recording of rotational behavior in rats after 6-hydroxydopamine lesions of the nigro-striatal dopamine system. Brain Res. 24, 485–493 (1970)Google Scholar
  55. Ungerstedt, U., Butcher, L. L., Butcher, S. G., Andén, N. E., Fuxe, K.: Direct chemical stimulation of dopaminergic mechanisms in the neostriatum of the rat. Brain Res. 14, 461–471 (1969)Google Scholar
  56. Volle, R. L., Koelle, G. B.: Ganglionic stimulating and blocking agents. In: The pharmacological basis of therapeutics, L. S. Goodman and A. Gilman, eds., pp. 585–600. New York: McMillan 1970Google Scholar
  57. Walters, J. R., Roth, R. H.: Dopaminergic neurons: drug-induced antagonism of the increase in tyrosine hydroxylase activity produced by cessation of impulse flow. J. Pharm. Pharmacol. 191, 82–91 (1974)Google Scholar
  58. Weil-Malberbe, H.: The chemical estimation of catecholamines and their metabolites in body fluids and tissue extracts. In: Analysis of biogenic amines and their related enzymes, D. G. Glick, ed., pp. 119–152. New York: Interscience Publishers 1971Google Scholar
  59. Weissman, A., Koe, B. K., Tenen, S. S.: Anti-amphetamine effects following inhibition of tyrosine hydroxylase. J. Pharmacol. exp. Ther. 151, 339–352 (1966)Google Scholar
  60. Zimmerberg, B., Glick, S. D., Jerussi, T. P.: Neurochemical correlate of a spatial preference in rats. Science 185, 623–625 (1974)Google Scholar

Copyright information

© Springer-Verlag 1976

Authors and Affiliations

  • Thomas P. Jerussi
    • 1
  • Stanley D. Glick
    • 1
  1. 1.Department of PharmacologyMount Sinai School of Medicine of the City University of New YorkNew YorkUSA

Personalised recommendations